Systematic Review of Algorithm-Guided Depression Treatment Trials

Seven randomized controlled trials with over 3,500 participants compare algorithm-guided treatment to treatment as usual for major depressive disorder. This systematic review, following PRISMA 2020 guidelines, synthesizes evidence on outcomes like remission time and treatment adherence. The analysis was conducted by Deni Rkman and published in March 2026.

Use Cases

• Compare remission rates between Algorithm Guided Treatment and Treatment As Usual groups across the seven included RCTs.
• Analyze time to remission as a primary outcome measure for structured depression treatment strategies.
• Assess treatment protocol adherence data to evaluate the feasibility of algorithm-guided care in clinical practice.
• Investigate outcome differences in studies involving comorbid populations mentioned in the review results.

Strengths

• Synthesizes data from over 3,500 participants across seven clinical trials.
• Follows the rigorous PRISMA 2020 guidelines for systematic review methodology.
• Focuses on a specific, clinically relevant comparison between two treatment frameworks for major depressive disorder.

Limitations

• The underlying data is a narrative synthesis in a 270.4 KB DOCX file, not a structured, machine-readable dataset for direct analysis.
• Limited to seven identified trials, which may not capture the full breadth of research on this topic.
• Clinical outcome data (e.g., specific remission rates) are summarized in the text and not provided in a raw, tabular format.

Provenance

Source

Systematic review conducted by author Deni Rkman, sourced from figshare.

Collection Method

Literature review of PubMed, Scopus, Embase, PsychInfo, and Cochrane Library databases for RCTs meeting specified inclusion criteria.

Time Range

Literature search covered studies up to June 2025.

Freshness

Last updated March 2026, with literature search up to June 2025.